By Arpan Chaturvedi and Shivam Patel
NEW DELHI (Reuters) – An Indian state regulator has suspended manufacturing licences of 14 products made by pharmaceutical companies of the country’s most popular yoga guru for repeatedly publishing misleading advertisements about their efficacy, a government order showed.
The manufacturing permits of yoga guru Baba Ramdev’s companies were suspended by the drug regulator of northern Uttarakhand state in an April 15 order which has not been made public but has been reviewed by Reuters.
A spokesperson for Ramdev said he did not have any immediate comment on the matter.
The Supreme Court of India has in recent weeks repeatedly criticized Ramdev for not complying with its directives in an ongoing lawsuit to stop misleading adverstisements of some of his traditional ayurvedic medicines.
The judges are considering whether to press contempt charges against Ramdev or not.
(Reporting by Arpan Chaturvedi; Editing by Aditya Kalra and Gareth Jones)
Disclaimer: This report is auto generated from the Reuters news service. ThePrint holds no responsibilty for its content.